SERPINB3 and esophageal adenocarcinoma: Regarding SerpinB3/4 as a serological biomarker, circulating levels of the free and IgM-linked forms have also been recently investigated in the prediction of the clinical outcomes of esophageal adenocarcinoma and associated with worse overall survival [45].